Could a common cholesterol pill be the key to fighting a devastating kidney disease?
Disease control
Not yet recruiting
This study tests whether bempedoic acid, a drug already approved for high cholesterol, can safely slow the progression of autosomal dominant polycystic kidney disease (ADPKD). About 120 adults with rapidly progressing ADPKD will take either the drug or a placebo for two years. Th…
Phase: PHASE2 • Sponsor: Kenneth Hallows • Aim: Disease control
Last updated May 11, 2026 20:41 UTC